SERPINE1 and metabolic syndrome: It is well established that the state of metabolic syndrome is characterized by defective endogenous fibrinolysis with an enhancement of fibrinolysis inhibitors like plasminogen activator inhibitor-1 (PAI-1) [27], which may account for decreased efficacy of clot lysis after rt-PA administration.